Literature DB >> 16931720

Reversal of the TCR stop signal by CTLA-4.

Helga Schneider1, Jos Downey, Andrew Smith, Bernd H Zinselmeyer, Catherine Rush, James M Brewer, Bin Wei, Nancy Hogg, Paul Garside, Christopher E Rudd.   

Abstract

The coreceptor cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is pivotal in regulating the threshold of signals during T cell activation, although the underlying mechanism is still not fully understood. Using in vitro migration assays and in vivo two-photon laser scanning microscopy, we showed that CTLA-4 increases T cell motility and overrides the T cell receptor (TCR)-induced stop signal required for stable conjugate formation between T cells and antigen-presenting cells. This event led to reduced contact periods between T cells and antigen-presenting cells that in turn decreased cytokine production and proliferation. These results suggest a fundamentally different model of reverse stop signaling, by which CTLA-4 modulates the threshold for T cell activation and protects against autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931720     DOI: 10.1126/science.1131078

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  257 in total

Review 1.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

Review 2.  Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma.

Authors:  Xiang-Yang Wang; Daming Zuo; Devanand Sarkar; Paul B Fisher
Journal:  Expert Opin Pharmacother       Date:  2011-12       Impact factor: 3.889

Review 3.  Cell surface signaling molecules in the control of immune responses: a tide model.

Authors:  Yuwen Zhu; Sheng Yao; Lieping Chen
Journal:  Immunity       Date:  2011-04-22       Impact factor: 31.745

4.  Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.

Authors:  Xuguang Tai; François Van Laethem; Leonid Pobezinsky; Terry Guinter; Susan O Sharrow; Anthony Adams; Larry Granger; Michael Kruhlak; Tullia Lindsten; Craig B Thompson; Lionel Feigenbaum; Alfred Singer
Journal:  Blood       Date:  2012-03-07       Impact factor: 22.113

5.  T-cell signaling and immunopathologies.

Authors:  Christopher E Rudd
Journal:  Semin Immunopathol       Date:  2010-06       Impact factor: 9.623

6.  T cell receptor "inside-out" pathway via signaling module SKAP1-RapL regulates T cell motility and interactions in lymph nodes.

Authors:  Monika Raab; Hongyan Wang; Yuning Lu; Xin Smith; Zhonglin Wu; Klaus Strebhardt; John E Ladbury; Christopher E Rudd
Journal:  Immunity       Date:  2010-03-25       Impact factor: 31.745

Review 7.  Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits.

Authors:  Renaud Snanoudj; Julien Zuber; Christophe Legendre
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 8.  Dynamics of dendritic cell-T cell interactions: a role in T cell outcome.

Authors:  Stéphanie Hugues
Journal:  Semin Immunopathol       Date:  2010-07-06       Impact factor: 9.623

9.  CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Authors:  Josef Kurtz; Forum Raval; Casey Vallot; Jayden Der; Megan Sykes
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

Review 10.  A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis.

Authors:  Eleanor A Fallon; Bethany M Biron-Girard; Chun-Shiang Chung; Joanne Lomas-Neira; Daithi S Heffernan; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2018-02-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.